Copyright: ©Author(s) 2026.
World J Virol. Sep 25, 2026; 15(3): 124097
Published online Sep 25, 2026. doi: 10.5501/wjv.124097
Published online Sep 25, 2026. doi: 10.5501/wjv.124097
Table 3 Comparative summary of key clinical evidence on cerebrospinal fluid metagenomic next-generation sequencing for central nervous system infection
| Ref. | Population/workflow | Main findings | Key limitations | Clinical interpretation |
| Wilson et al[22]; prospective, multicenter | 204 patients with meningitis/encephalitis; clinical adjudication against conventional testing | 58 infections in 57 patients; 13/58 (22%) identified only by mNGS; 8/13 likely clinical effect; 7/13 guided treatment | Missed 11 serology-only, 7 non-CSF/tissue, and 8 low-titer infections | Adds actionable diagnoses but cannot replace serology, tissue testing, or targeted assays |
| Xing et al[25]; prospective, multicenter | 213 patients with suspected infectious encephalitis/meningitis | mNGS positivity 57% in definite CNS infection and 42.6% in definite viral disease; AUC 0.659 at SSRN ≥ 2 | Performance depends on threshold, case definition, and pathogen spectrum | Useful in selected unresolved cases; yield is not uniform across disease groups |
| Qu et al[27]; systematic review and meta-analysis | 12 studies; heterogeneous populations, assays, reference standards, and thresholds | Pooled sensitivity 77% (95%CI: 70%-82%); specificity 96% (95%CI: 93%-98%); AUC 0.91; viral subgroup 82%/97% | Specificity heterogeneity I2 = 72.07%; too few non-Illumina studies for platform comparison | Pooled accuracy is promising but should not be applied as a universal assay estimate |
| Benoit et al[28]; seven-year clinical performance | 4828 CSF samples; adjudicated subset included 220 CNS infections | 14.4% of samples positive; mNGS alone identified 48/220 infections (21.8%); sensitivity 63.1%, specificity 99.6%, accuracy 92.9% | Sensitivity rose to 86% against CSF direct detection alone, illustrating reference-standard effects | High specificity and meaningful incremental yield, with persistent sensitivity gaps |
- Citation: Binay UD, Karakeçili F, Barkay O, Sümer B. Metagenomic next-generation sequencing in the diagnosis of viral encephalitis. World J Virol 2026; 15(3): 124097
- URL: https://www.wjgnet.com/2220-3249/full/v15/i3/124097.htm
- DOI: https://dx.doi.org/10.5501/wjv.124097